(Date:12/1/2008)...PRNewswire-FirstCall/ -- Mach One Corporation,(Pi...hat develops products,that produce a positive lon...arket, announced today that Mr. Tad Ballantyne wil... upon the closing of the acquisition of Pacific Ri...antyne is an officer and/or director of a number o...
(Date:12/1/2008)...wswire/ -- To help prevent the spread of germs and...ial Hospital is using two new,products that kill ... According to Infection Prevention Director L...search study of Germ Pro,s new surface disinfectan... they work and was excited by the,results. , ...
(Date:12/1/2008)...RNewswire/ -- Organogenesis, Inc., a leading,rege... recipient of two,prestigious awards honoring the...g and economic impact. , Organogenesis, man...he,Year" by Pharmaceutical Manufacturing, a promi..." honor will be highlighted in the magazine,s upco...
(Date:12/1/2008)...PRNewswire/ -- Welvista is pleased to announce it,..., one of the world,s leading,pharmaceutical compa...,uninsured through Welvista,s no-cost prescriptio...nofi-aventis drugs from the company,s Patient Assi...s on its formulary for the,uninsured. Including s...
Breaking Medicine News(10 mins):Health News:Mr. Tad Ballantyne to Join Mach One Board of Directors 2Health News:MRSA and C. difficile Infections Reduced by 50% in Hospital Study 2Health News:MRSA and C. difficile Infections Reduced by 50% in Hospital Study 3Health News:Organogenesis Receives Two Prestigious Awards for Economic Impact and Manufacturing Excellence 2Health News:Organogenesis Receives Two Prestigious Awards for Economic Impact and Manufacturing Excellence 3Health News:Organogenesis Receives Two Prestigious Awards for Economic Impact and Manufacturing Excellence 4Health News:Welvista Announces Partnering with sanofi-aventis U.S. to Provide Medication at No Cost to the Uninsured 2(Date:11/27/2008)...nds the majority of acute lymphoblastic leukemia r...the time of diagnosis , , MEMPHIS, Tenn., N.... Jude Children,s Research Hospital have identifie...of children with acute lymphoblastic leukemia (ALL... to designing treatments for ALL relapse in childr...
(Date:11/26/2008)...formation density, automation and intelligent clin...asound to an all new level , , CHICAGO, Ill...althcare ( www.siemens.com/healthcare ) highligh...anner (ABVS)(1), the world,s first multi-use, aut...h Scientific Assembly and Annual Meeting of the Ra...
(Date:11/25/2008)...eness can improve recovery , , Audio and We...lable on the Mayo Clinic News Blog. Please see the... ROCHESTER, Minn., Nov. 25 /PRNewswire-USNewswir...ke patients don,t think they,re having a stroke --...their condition worsens. The findings appear in th...
(Date:11/25/2008)...al most respondents against expanding statin use b...ITTLE FALLS, N.J., Nov. 25 JUPITER...er the cardiovascular risk of healthy patients wit... use in older adults, according to a national poll...icipants took part in the online poll conducted by...
Breaking Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3HTH Worldwide Unveils First Digital Healthcare Card 27774 1HTH Worldwide Unveils First Digital Healthcare Card 27774 2Rheumatoid Arthritis Rising Among U S Women 27772 1Healing process found to backfire in lung patients 27769 1Healing process found to backfire in lung patients 27769 2St Davids HealthCare Launches The TIA Center for Stroke Prevention at St Davids Medical Center 27766 1St Davids HealthCare Launches The TIA Center for Stroke Prevention at St Davids Medical Center 27766 2St Davids HealthCare Launches The TIA Center for Stroke Prevention at St Davids Medical Center 27766 3...ne flow over 28-week period, QUEBEC CITY, May 23, .... , a global biopharmaceutical company focused on,...at its partner,Spectrum Pharmaceuticals presented ... AEterna Zentaris, fourth-generation luteinizing,h...zarelix, in,benign prostatic hyperplasia (BPH). Re...
...otherapy drug,docetaxel currently offers the best .... That is the result of a now,published clinical t...dely used chemotherapy drugs. When using docetaxel...than 50% than when using the,next-best chemotherap...e cancer has rapidly,grown in importance over rece...
Other Medicine Technology:AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2,Data for Ozarelix, in BPH at Annual AUA Meeting 2AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2,Data for Ozarelix, in BPH at Annual AUA Meeting 3AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2,Data for Ozarelix, in BPH at Annual AUA Meeting 4AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2,Data for Ozarelix, in BPH at Annual AUA Meeting 5Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of,Docetaxel Chemotherapy 2Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of,Docetaxel Chemotherapy 3Thrombin Activatable Fibrinolysis Inhibitor Assay Kit
Pefakit in-TDT Calibrators and Controls
PT-HS with Calcium - 2 ml
Plasma Control Level 1 - 1 ml
Medicine Products: